Increased synthesis of thromboxane A2 and expression of procoagulant activity by monocytes in response to arachidonic acid in diabetes mellitus

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 65, Issue 3, 2001, Pages 133-138

  Konieczkowski, M ^a   Skrinska, V A ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; PROCOAGULANT; THROMBOXANE A2;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBRIN DEPOSITION; HUMAN; MALE; MONOCYTE; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOSIS; VASCULAR DISEASE;

EID: 0035178346     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0301     Document Type: Article

References (34)

1. Platelets in diabetes: The role in the hemostatic regulation in atherosclerosis
2. Cardiovascular sensitivity changes to eicosanoids in rats with experimentally induced diabetes mellitus
3. Thromboxane production and platelet aggregatin in diabetic subjects with clinical complications
4. Insulin and arachidonic acid metabolism in diabetes mellitus
5. Increased platelet arachidonic acid metabolism in diabetes Mellitus
6. Platelet glutathione and thromboxane synthesis in diabetes
7. Behavior of intracellular glutathione during platelet thromboxane synthesis in diabetes
8. Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes
9. Platelet thromboxane synthesizing activity in non-insulin-dependent diabetes: Correlation with diabetic retinopathy and diabetic treatment
10. 2 as markers of real platelet hyperactivation in diabetic nephropathy
11. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease
12. Thromboxane biosynthesis and platelet function in type II diabetes mellitus
13. 2
14. Primary platelet activation in recent-onset type 1 diabetes mellitus
15. Decreased vascular prostacyclin in juvenile-onset diabetes
16. Decreased vascular prostacyclin in experimental diabetes
17. Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: Abnormalities in diabetics
18. Cloning factors secreted by monocytes and macrophages: Analytical considerations
19. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatraenoic Acid
20. Cellular receptors for advanced glycation end products. Implications for reduction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
21. Advanced protein glycosylation reduces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging
22. Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation
23. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
24. Increased adhesion of lymphoid cells to glycated proteins
25. Distinctive features of procoagulant response of monocytes from diabetic patients
26. Modifications of monocyte procoagulant activity in diabetes mellitus
27. Arachidonic acid metabolism by human monocytes: Studies with platelet-depleted cultures
28. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans
29. 2 synthase (cyclooxygenase) in human monocytes
30. 2 Synthesis
31. Concanavalin A inhibition of tissue factor (thromboplastin) activity
32. The phospholipid requirement of tissue factor in blood coagulation
33. 2 inhibitor: Importance of activated monocytes
34. Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro